IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Euclidean Capital LLC

Portfolio Profile

CIK: 0001825034 | NEW YORK, NY

Investment Profile

Style

ETF

Turnover

Low

Orientation

Concentrated long-term
$439.8M
AUM
11
Positions
100%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Vanguard Intl Equity Index F(VEU)3,243,484$271.6M61.76%
2Vanguard Index FDS(VTV)520,000$113.3M25.77%
3Ishares TR(INDA)369,600$18.3M4.15%
4Oric Pharmaceuticals Inc(ORIC)989,410$10.7M2.44%
5Teamshares Inc(TMS)1,099,974$9.0M2.06%
6

Sector Allocation

Latest filing, equity positions only

Unclassified93.73% · $412.3M
Healthcare6.27% · $27.6M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare7.49%6.27%-1.22%
Unclassified92.51%93.73%+1.22%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$458.4M | 13 pos.
$888.5M | 13 pos.
$780.0M | 13 pos.
$795.8M | 11 pos.
$906.8M | 12 pos.
$736.7M | 11 pos.
Foghorn Therapeutics Inc(FHTX)
1,573,761
$7.7M
1.75%
7PMV Pharmaceuticals Inc(PMVP)2,627,643$3.5M0.80%
8Alector Inc(ALEC)1,307,858$2.6M0.60%
9Surrozen Inc(SRZN)87,696$2.3M0.52%
10Tenaya Therapeutics Inc(TNYA)1,015,705$750.7K0.17%
Cap SizePrev %Curr %Change
Unclassified92.51%93.73%+1.22%
Micro Cap4.3%3.83%-0.47%
Small Cap3.2%2.44%-0.76%
$266.1M | 11 pos.
$305.7M | 11 pos.
$238.0M | 11 pos.
$369.5M | 12 pos.
$392.3M | 10 pos.
$439.8M | 11 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

1
New
0
Closed
0
Increased
0
Decreased
10
Unchanged